CGT Analytical Consulting

Services

Strategic. Scientific. Integrated

Comprehensive analytical solutions designed to de-risk development and accelerate your path to patients

1

Interim Leadership & Strategic Advisory

Experienced scientific leadership and strategic guidance to strengthen analytical organizations, align cross-functional teams, and advance development programs.

  • Interim and fractional Analytical Development leadership
  • Analytical and CMC strategy across development stages
  • Program roadmaps aligned with technical, regulatory, and business milestones
  • Oversight of CROs, CDMOs, external laboratories, and technology partners
2

Analytical & Quality Strategy

Integrated analytical strategies designed to support product understanding, process development, quality control, and regulatory readiness.

  • Phase-appropriate analytical control strategies
  • Critical quality attribute and product characterization strategies
  • Analytical platform and technology strategy
  • Alignment of analytical capabilities with product quality and biological function
3

Assay Development & Product Characterization

Scientific and technical support for developing robust analytical capabilities and establishing a comprehensive understanding of product quality and performance.

  • Analytical method and assay development
  • Potency and functional characterization
  • Product characterization and structure-function assessment
  • Analytical technology evaluation and implementation
4

Comparability & Analytical Lifecycle Management

Risk-based strategies to support process changes, technology transfer, method evolution, and continued analytical performance throughout the product lifecycle.

  • Analytical comparability and bridging strategies
  • Method qualification, validation, and transfer strategy
  • Specification development and analytical performance monitoring
  • Critical reagent and method lifecycle management
5

Stability & Regulatory Support

Integrated analytical and CMC support to strengthen regulatory submissions, stability programs, and inspection readiness from clinical development through commercialization.

  • Stability and shelf-life strategy
  • Analytical and CMC regulatory support
  • IND, BLA, and lifecycle submission support
  • Regulatory interaction and inspection readiness